Publicacions en col·laboració amb investigadors/es de Hospital Universitario Virgen de las Nieves (24)

2023

  1. Baseline extracellular vesicle miRNA-30c and autophagic CTCs predict chemoradiotherapy resistance and outcomes in patients with lung cancer

    Biomarker Research

  2. Circulating tumor cells in cancer-risk populations as a cancer interception tool

    International Review of Cell and Molecular Biology (Elsevier Inc.), pp. 113-129

  3. Editorial: Current trends and future perspectives about liquid biopsy

    Frontiers in Genetics

  4. microRNAs signature in relapse metastasis and de novo metastasis of breast cancer. A systematic review

    Critical Reviews in Oncology/Hematology, Vol. 188

2022

  1. A Novel, Quick, and Reliable Smartphone-Based Method for Serum PSA Quantification: Original Design of a Portable Microfluidic Immunosensor-Based System

    Cancers, Vol. 14, Núm. 18

  2. Editorial: Tumor Microenvironment and Cancer Cell Interactions in Solid Tumor Growth and Therapy Resistance

    Frontiers in Cell and Developmental Biology

  3. Exchange of cellular components between platelets and tumor cells: impact on tumor cells behavior

    Theranostics, Vol. 12, Núm. 5, pp. 2150-2161

  4. Hepatocellular carcinoma risk-stratification based on ASGR1 in circulating epithelial cells for cancer interception

    Frontiers in Molecular Biosciences, Vol. 9

  5. Identification of hereditary breast and ovarian cancer germline variants in Granada (Spain): NGS perspective

    Molecular Genetics and Genomics, Vol. 297, Núm. 3, pp. 859-871

2021

  1. Cross‐resistance to abiraterone and enzalutamide in castration resistance prostate cancer cellular models is mediated by ar transcriptional reactivation

    Cancers, Vol. 13, Núm. 6, pp. 1-21

  2. Deep phenotypic characterisation of CTCs by combination of microfluidic isolation (Isoflux) and imaging flow cytometry (imagestream)

    Cancers, Vol. 13, Núm. 24

2020

  1. Extracellular vesicle-miRNAs as liquid biopsy biomarkers for disease identification and prognosis in metastatic colorectal cancer patients

    Scientific Reports, Vol. 10, Núm. 1

  2. From precision medicine to imprecision medicine through limited diagnostic ability to detect low allelic frequency mutations

    Translational Lung Cancer Research, Vol. 9, Núm. 2, pp. 180-183

  3. Precision prevention and cancer interception: The new challenges of liquid biopsy

    Cancer Discovery, Vol. 10, Núm. 11, pp. 1635-1644

  4. Strategies for isolation and phenotypic, genetic, and functional characterization of circulating tumor cells

    Cancers

  5. The polemic diagnostic role of TP53 mutations in liquid biopsies from breast, colon and lung cancers

    Cancers, Vol. 12, Núm. 11, pp. 1-17

2019

  1. Cooperative and Escaping Mechanisms between Circulating Tumor Cells and Blood Constituents

    Cells, Vol. 8, Núm. 11

  2. Post-surgery circulating tumor cells and AXL overexpression as new poor prognostic biomarkers in resected lung adenocarcinoma

    Cancers, Vol. 11, Núm. 11

2018

  1. Genetic markers a landscape in prostate cancer

    Mutation Research - Reviews in Mutation Research, Vol. 775, pp. 1-10

2017

  1. Association between polymorphisms in sex hormones synthesis and metabolism and prostate cancer aggressiveness

    PLoS ONE, Vol. 12, Núm. 10